The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Receptor desensitisation as a tolerance hypothesis, and its weak evidence

This is a generated summary. It shows the 8 most-liked posts from a topic of 58, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
OV
o.vukovicTL223 May 2026#3

Species differences in receptor pharmacology are substantial in this family, which is one reason rodent data has translated unevenly.

Take the reasoning and check the arithmetic; I do not always get it right.

25 likes 2mo
FN
f.novakTL219 Jun 2026#22

Right, and stated more narrowly than I would have dared to state it.

26 likes 1mo
WV
w.verhoevenTL230 Jun 2026#31

I read the earlier replies on receptor desensitisation twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.

28 likes 28d
WP
weekly_pinTL2Regular10 Jul 2026#40

Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the same stimulus with repeated exposure). Both might affect long-term response to these compounds.

I am describing what is, rather than arguing for what should be.

29 likes 18d
SK
s.karlsen_rphTL3Pharmacist12 Jul 2026#42

This follows post #41 rather than contradicting it.

The number people quote for receptor desensitisation is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on its own.

21 likes 16d
CV
c.vasquezTL215 Jul 2026#45

That reframing is the whole thing. The facts I already had.

30 likes 13d
CC
c.correiaTL219 Jul 2026#49

GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin secretion. Attributing everything to one of them is where most simplified accounts go wrong.

If anyone has run this properly I would rather read that than my own guess.

22 likes 9d
NS
n.szaboTL224 Jul 2026#54

Where the receptor desensitisation reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.

23 likes 4d

Read the full topic (58 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Biased agonism: a real phenomenon, an over-used explanation — what changed since
Biased agonism: a real phenomenon, an over-used explanation — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Biased agonism is…
EKJHROKFEK+49 56 47k 17mo
Follow-up: Glucagon receptor agonism in a weight-loss compound
Glucagon receptor agonism in a weight-loss compound Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about Glucagon receptor agonism that I did not know…
AMHNDNLAMD+5 9 21k 7mo
GLP-1 receptor distribution: central and peripheral
Posting this under the heading it deserves: GLP-1 receptor distribution: central and peripheral Everything below is what sits behind that. I have spent a fortnight trying to pin GLP-1 receptor distribution…
KHBPJNNSNH+90 98 30k 22h
Why appetite effects are mostly central
Why appetite effects are mostly central I have a specific reason for asking rather than idle curiosity, and the context is below. Appetite effects: what I expected, what I found, and the gap between them. I…
EKHFSB 2 56k 16mo
Vagal afferents and the gut-brain pathway
On the subject in the title: Vagal afferents and the gut-brain pathway Working notes rather than a conclusion. Vagal afferents — I have the observation and I do not trust my interpretation of it, so I am…
KRBSKSBCD+5 9 44k 13mo

Related topics — sharing the tags tirzepatide, retatrutide, amylin analogues

TopicParticipantsRepliesViewsActivity
Semaglutide formulation: what is in the licensed product besides the peptide
Semaglutide formulation: what is in the licensed product besides the peptide — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin semaglutide…
VSNTEKSPEK+29 35 4.4k 1h
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully
Semaglutide versus liraglutide head to head: reading STEP 8 carefully — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on…
DYKBFHKVM+1 5 11k 20mo
Second pass at: Semaglutide and alcohol: what is actually documented
Second pass at: Semaglutide and alcohol: what is actually documented Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers…
IBDNOFID+15 19 4.4k 13mo
Why cagrilintide alone is discussed so much less than in combination
Why cagrilintide alone is discussed so much less than in combination I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known about cagrilintide alone…
MENVRFCHKB+93 108 35k 16mo
Peak-to-trough ratio at steady state for a weekly agent
On the subject in the title: Peak-to-trough ratio at steady state for a weekly agent Working notes rather than a conclusion. Working through the kinetics rather than the pharmacology, because I think the…
SMVNICPAJH+58 64 9.7k 2mo